BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25319490)

  • 1. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of TRPVs in the cholesteatoma epithelium.
    Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
    Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
    Nguyen KH; Suzuki H; Ohbuchi T; Wakasugi T; Koizumi H; Hashida K; Baba R; Morimoto H; Doi Y
    Laryngoscope; 2014 Jan; 124(1):245-50. PubMed ID: 24122656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical Impedance and Expression of Tight Junction Components of the Nasal Turbinate and Polyp.
    Suzuki H; Koizumi H; Ikezaki S; Tabata T; Ohkubo J; Kitamura T; Hohchi N
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(1):16-25. PubMed ID: 26633876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
    Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
    Koizumi H; Kawaguchi R; Ohkubo JI; Ikezaki S; Kitamura T; Hohchi N; Hashida K; Suzuki H
    Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ; Sidey C; Narula AA; James RF
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
    Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
    Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double mutation of claudin-1 and claudin-3 causes alopecia in infant mice.
    Suzuki K; Yamaga K; Tokumasu R; Katsuno T; Tanaka H; Chiba S; Yagi T; Katayama I; Tamura A; Murota H; Tsukita S
    Ann N Y Acad Sci; 2023 May; 1523(1):51-61. PubMed ID: 37002535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of PTKs CDK4 and p15 in the middle ear cholesteatomatous epithelium].
    Sun W; Xu Z; Tang A; Su J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):616-9. PubMed ID: 15620145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
    Ren X; Cui P; Chen W; Xu M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential expression of toll-like receptors in chronic suppurative otitis media and cholesteatoma].
    Si Y; Zhang ZG; Huang CY; He JF; Feng LQ; Chen YB; Chen T; Huang X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):388-93. PubMed ID: 22883581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.